Celonic AG:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Celonic AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11247
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Celonic AG (Celonic), a subsidiary of JRS Pharma LP is a biotechnology company that offers contract development manufacturing organization services. The company’s services include development of cell lines and biotechnological production processes, full GMP analytics, and manufacture of active pharmaceutical ingredients and product batches for clinical trials. Its SEFEX is a proprietary, royalty-free host system and a cell line development platform used for the generation of cell lines for new biological entities and biosimilar products. The company operates through its manufacturing facility located in France, Germany and Switzerland. Celonic is headquartered in Basel, Switzerland.

Celonic AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Celonic AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Celonic AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Celonic AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Celonic AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Celonic AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Celonic AG, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Celonic Acquires Bio-Manufacturing Facility from Glycotope 10
Partnerships 11
Heidelberg Pharma Enters into Agreement with Celonic 11
Istituto Biochimico Italiano Giovanni Lorenzini Enters into Agreement with Celonic 12
Fusion Antibodies Enters into Partnership with Celonic 13
Protagen Protein Services, Assign International, Aurigon, Celonic and PharmaLex Form Joint Venture 14
Licensing Agreements 15
Trenzyme Enters into Licensing Agreement with Celonic 15
Celonic AG – Key Competitors 16
Celonic AG – Key Employees 17
Celonic AG – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Joint Venture 18
Recent Developments 19
Strategy And Business Planning 19
Sep 13, 2017: Merck Expands Celonic’s Upstream Capabilities with Mobius Single-use Bioreactors 19
Corporate Communications 20
May 08, 2018: Celonic Appoints Soenke Brunswieck as Vice President Cell & Gene Therapy 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Celonic AG, Pharmaceuticals & Healthcare, Key Facts 2
Celonic AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Celonic AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Celonic AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Celonic AG, Deals By Therapy Area, 2012 to YTD 2018 8
Celonic AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Celonic Acquires Bio-Manufacturing Facility from Glycotope 10
Heidelberg Pharma Enters into Agreement with Celonic 11
Istituto Biochimico Italiano Giovanni Lorenzini Enters into Agreement with Celonic 12
Fusion Antibodies Enters into Partnership with Celonic 13
Protagen Protein Services, Assign International, Aurigon, Celonic and PharmaLex Form Joint Venture 14
Trenzyme Enters into Licensing Agreement with Celonic 15
Celonic AG, Key Competitors 16
Celonic AG, Key Employees 17
Celonic AG, Joint Venture 18

List of Figures
Celonic AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Celonic AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Celonic AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Celonic AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Celonic AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Celonic AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Celonic AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Celonic AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Celonic AG:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Odfjell Drilling Ltd (ODL):石油・ガス:M&Aディール及び事業提携情報
    Summary Odfjell Drilling Ltd (Odfjell) is an integrated offshore drilling and oil service company. It operates a fleet of harsh and ultra-deepwater mobile offshore drilling units and provides platform drilling and well services. The company's drilling technology offers conceptual engineering and des …
  • Vectura Group plc:企業の戦略・SWOT・財務分析
    Vectura Group plc - Strategy, SWOT and Corporate Finance Report Summary Vectura Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Societe Electrique de l’Our SA:企業の戦略的SWOT分析
    Societe Electrique de l'Our SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Yanlord Land Group Ltd:企業の戦略・SWOT・財務情報
    Yanlord Land Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Yanlord Land Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Aeglea BioTherapeutics Inc (AGLE)-製薬・医療分野:企業M&A・提携分析
    Summary Aeglea BioTherapeutics Inc (Aeglea BioTherapeutics), formerly Aeglea BioTherapeutics Holdings, LLC is a biotechnology company that develops and commercializes engineered human enzymes for the treatment of cancer and rare genetic diseases. The company’s product pipeline comprises AEB1102, AEB …
  • Australian Securities & Investments Commission:企業の戦略的SWOT分析
    Australian Securities & Investments Commission - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitor …
  • Marina Portoroz d.d.:企業の戦略・SWOT・財務情報
    Marina Portoroz d.d. - Strategy, SWOT and Corporate Finance Report Summary Marina Portoroz d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Mead Johnson Nutrition Co:企業の戦略的SWOT分析
    Mead Johnson Nutrition Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • NGM Biopharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NGM Biopharmaceuticals Inc (NGM Bio) is a clinical-stage biopharmaceutical company that develops pipeline of biological therapeutics for the treatment of cardio-metabolic, immuno-oncology, retinal and liver diseases. The company’s pipeline products include NGM282, NGM386, NGM395, NGM621, NGM …
  • Fortis Inc.:企業の戦略・SWOT・財務分析
    Fortis Inc. - Strategy, SWOT and Corporate Finance Report Summary Fortis Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • PBF Energy Inc. (PBF)-石油・ガス分野:企業M&A・提携分析
    Summary PBF Energy Inc. (PBF Energy) is an independent oil refining company. It owns and operates crude oil refineries and related facilities in the US. Its refining assets include Delaware City refinery, Delaware; Paulsboro refinery, New Jersey; Chalmette refinery, Louisiana, Torrance, California a …
  • Altice Europe Nv:企業の戦略・SWOT・財務分析
    Altice Europe Nv - Strategy, SWOT and Corporate Finance Report Summary Altice Europe Nv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • China Everbright Ltd (165):企業の財務・戦略的SWOT分析
    China Everbright Ltd (165) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Allianz Global Corporate & Specialty Singapore
    Allianz Global Corporate & Specialty Singapore - Strategy, SWOT and Corporate Finance Report Summary Allianz Global Corporate & Specialty Singapore - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Parsons Corporation:企業の戦略・SWOT・財務分析
    Parsons Corporation - Strategy, SWOT and Corporate Finance Report Summary Parsons Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Westfalen Weser Netz GmbH:企業の戦略的SWOT分析
    Westfalen Weser Netz GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Fichtner GmbH & Co KG:企業の戦略的SWOT分析
    Fichtner GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • ToolGen Inc-製薬・医療分野:企業M&A・提携分析
    Summary ToolGen Inc (ToolGen) is a genome editing company that concentrates on translating the genetic knowledge into transformative products for biomedicine and agriculture. The company creates intellectual property rights for essential tools and technologies for editing the genetic information in …
  • Centrotec Sustainable AG (CEV):企業の財務・戦略的SWOT分析
    Summary Centrotec Sustainable AG (Centrotec) is an energy company that provides energy saving systems. The company provides products such as medical technology plastics, climate systems, gas flue systems and engineering plastics, among others. It also offers ventilation with heat recovery, heating s …
  • Emgesa SA ESP:企業の戦略的SWOT分析
    Emgesa SA ESP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆